ORIENTBIO Inc. (002630) — Cash Flow Reinvestment Rate
ORIENTBIO Inc. (002630) has a Cash Flow Reinvestment Rate of 0.26x as of December 2025, reinvesting ₩467.25 Million (capex ₩452.25 Million plus investments ₩-15.00 Million) from operating cash flow of ₩1.77 Billion. See ORIENTBIO Inc. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ORIENTBIO Inc. Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for ORIENTBIO Inc. across 12 annual periods. For the full cash flow conversion analysis, see ORIENTBIO Inc. (002630) cash flow conversion.
Annual Cash Flow Reinvestment Rate for ORIENTBIO Inc. (2007–2025)
Year-by-year capital reinvestment analysis for ORIENTBIO Inc.. See ORIENTBIO Inc. free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 7.67x | ₩5.77 Billion | ₩752.29 Million | ₩4.79 Billion | ▲ +2420.9% |
| 2024 | 0.30x | ₩1.14 Billion | ₩3.76 Billion | ₩925.25 Million | ▼ -98.1% |
| 2023 | 16.12x | ₩18.70 Billion | ₩1.16 Billion | ₩485.64 Million | ▲ +314.8% |
| 2022 | 3.89x | ₩9.14 Billion | ₩2.35 Billion | ₩2.21 Billion | ▲ +8953.9% |
| 2021 | 0.04x | ₩375.16 Million | ₩8.74 Billion | ₩256.16 Million | ▼ -99.7% |
| 2016 | 16.17x | ₩14.76 Billion | ₩912.43 Million | ₩14.46 Billion | ▲ +233.8% |
| 2015 | 4.84x | ₩7.77 Billion | ₩1.60 Billion | ₩5.11 Billion | ▼ 0.0% |
| 2014 | 4.85x | ₩10.51 Billion | ₩2.17 Billion | ₩10.43 Billion | ▲ +30.3% |
| 2013 | 3.72x | ₩18.94 Billion | ₩5.09 Billion | ₩18.94 Billion | ▲ +289.9% |
| 2011 | 0.95x | ₩2.97 Billion | ₩3.11 Billion | ₩2.97 Billion | ▲ +460.7% |
| 2010 | 0.17x | ₩1.59 Billion | ₩9.35 Billion | ₩1.59 Billion | ▼ -97.9% |
| 2007 | 8.11x | ₩12.30 Billion | ₩1.52 Billion | ₩12.30 Billion | — |